Thais Sielecki
Geschäftsführer bei Polycore Therapeutics, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Barbara L. Powers | M | - |
Cytokine PharmaSciences, Inc.
 Cytokine PharmaSciences, Inc. Pharmaceuticals: MajorHealth Technology Cytokine PharmaSciences, Inc. operates as a biopharmaceutical company. It develops and manufactures drug delivery products. The firm involves in developing controlled-release drug delivery products in the area of women's health; and small molecule therapeutics in the areas of autoimmune diseases, anti-inflammation, and cancer. The company was founded in June 1999 and is headquartered in Conshohocken, PA. | 20 Jahre |
| Kelly Beck | F | 48 |
Polycore Therapeutics, Inc.
 Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck. | - |
| Sandhya Kortagere | F | - |
Polycore Therapeutics, Inc.
Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck. | - |
| Jim Harris | M | - |
Polycore Therapeutics, Inc.
Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck. | - |
| Christopher Garabedian | M | 57 |
Polycore Therapeutics, Inc.
Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck. | - |
| Christopher Michael Cashman | M | 67 |
Polycore Therapeutics, Inc.
Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck. | - |
| Dennis F. Willson | M | - |
Cytokine PharmaSciences, Inc.
Cytokine PharmaSciences, Inc. Pharmaceuticals: MajorHealth Technology Cytokine PharmaSciences, Inc. operates as a biopharmaceutical company. It develops and manufactures drug delivery products. The firm involves in developing controlled-release drug delivery products in the area of women's health; and small molecule therapeutics in the areas of autoimmune diseases, anti-inflammation, and cancer. The company was founded in June 1999 and is headquartered in Conshohocken, PA. | - |
| Frederick Callori | M | 56 |
Polycore Therapeutics, Inc.
Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Polycore Therapeutics, Inc. is a biopharmaceutical company that develops treatments for patients with neurodegenerative disorders. The company is based in Philadelphia, PA. Polycore Therapeutics was founded by Sandhya Kortagere, Jim Harris. The company is currently conducting preclinical studies for its lead compound, PCT-3012, a novel small molecule for the treatment of Parkinson's motor symptoms and in patients with early- to mid-stage Parkinson's disease. The CEO is Kelly Beck. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Cameron Macdonald | M | - |
Cytokine PharmaSciences, Inc.
Cytokine PharmaSciences, Inc. Pharmaceuticals: MajorHealth Technology Cytokine PharmaSciences, Inc. operates as a biopharmaceutical company. It develops and manufactures drug delivery products. The firm involves in developing controlled-release drug delivery products in the area of women's health; and small molecule therapeutics in the areas of autoimmune diseases, anti-inflammation, and cancer. The company was founded in June 1999 and is headquartered in Conshohocken, PA. | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 9 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Thais Sielecki
- Persönliches Netzwerk
